Potential for Nuclear Medicine Therapy for Glioblastoma Treatment

Author:

Bailly Clément,Vidal Aurelien,Bonnemaire Coralie,Kraeber-Bodéré Françoise,Chérel Michel,Pallardy Amandine,Rousseau Caroline,Garcion Emmanuel,Lacoeuille Franck,Hindré François,Valable Samuel,Bernaudin Myriam,Bodet-Milin Caroline,Bourgeois Mickaël

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference70 articles.

1. Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study;Akabani;J. Nucl. Med.,2005

2. Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors;Akabani;J. Nucl. Med.,1999

3. Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide;Bartolomei;Q. J. Nucl. Med. Mol. Imaging.,2004

4. Remodeling the vascular microenvironment of glioblastoma with α-particles;Behling;J. Nucl. Med.,2016

5. Vascular targeted radioimmunotherapy for the treatment of glioblastoma;Behling;J. Nucl. Med.,2016

Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3